AbbVie, headquartered in North Chicago, Illinois, is a leading American biopharmaceutical company dedicated to the discovery, development, and delivery of advanced therapies to address serious health conditions. Established in 2013 after its spinoff from Abbott Laboratories, AbbVie has made remarkable strides in areas such as immunology, oncology, virology, and neuroscience. The company is recognized for its commitment to innovation, improving patient outcomes, and advancing science through cutting-edge research and development.
AbbVie’s primary focus is on developing breakthrough treatments for some of the world’s most challenging diseases. Its flagship products, including Humira and Imbruvica, have helped millions of patients globally. Through strategic acquisitions and partnerships, AbbVie has strengthened its position as a global biopharmaceutical giant. As of 2024, AbbVie operates in more than 175 countries and continues to expand its research capabilities to develop new therapies.
CEO and Founder of AbbVie
AbbVie was founded as a result of a spinoff from Abbott Laboratories in 2013. The decision to separate the pharmaceutical division into an independent company was driven by the desire to focus more intensively on biopharmaceutical innovation. AbbVie’s first CEO was Richard A. Gonzalez, who continues to lead the company in 2024. Under his leadership, AbbVie has grown into one of the largest and most successful biopharmaceutical companies in the world, with a focus on advancing therapies in key therapeutic areas such as immunology, oncology, and neurology. Gonzalez’s strategic vision, including the acquisition of Allergan in 2020, has significantly expanded AbbVie’s portfolio, adding several high-growth drugs and aesthetic products to its range.
List of Top Companies Under AbbVie
AbbVie has expanded its business through strategic acquisitions and partnerships, allowing it to grow its therapeutic offerings and global reach. Below is a list of some of the top companies and brands under AbbVie, along with their valuations.
| Company/Brand Name | Year Acquired/Founded | Valuation | Industry |
|---|---|---|---|
| Allergan | 2020 (Acquired) | $63 Billion | Aesthetics, Pharmaceuticals |
| Pharmacyclics | 2015 (Acquired) | $21 Billion | Oncology |
| Stemcentrx | 2016 (Acquired) | $5.8 Billion | Cancer Research |
| ImmuVen | 2016 (Acquired) | Valuation not disclosed | Immuno-oncology |
| Mavupharma | 2019 (Acquired) | Valuation not disclosed | Cancer Therapy Development |
| Botox (Allergan product) | 2020 (Part of Allergan) | $4.6 Billion | Aesthetics |
| Juvederm (Allergan product) | 2020 (Part of Allergan) | $1 Billion | Aesthetic Dermatology |
FAQs About AbbVie
Q1: When was AbbVie founded, and how did it come into existence?
A: AbbVie was founded in 2013 as a spinoff from Abbott Laboratories to focus on developing biopharmaceutical therapies.
Q2: Who is the CEO of AbbVie?
A: Richard A. Gonzalez is the CEO of AbbVie. He has led the company since its inception in 2013.
Q3: What are AbbVie’s major products?
A: AbbVie’s major products include Humira, Imbruvica, Skyrizi, Botox (through its acquisition of Allergan), and Rinvoq, among others.
Q4: What is the significance of AbbVie’s acquisition of Allergan?
A: The acquisition of Allergan in 2020 allowed AbbVie to diversify its product offerings, particularly in the fields of aesthetics and neuroscience, with flagship products like Botox and Juvederm.
Q5: In which therapeutic areas does AbbVie specialize?
A: AbbVie specializes in immunology, oncology, virology, neuroscience, and aesthetics.
Q6: What is AbbVie’s global presence?
A: AbbVie operates in over 175 countries and employs more than 50,000 people worldwide.
Q7: Does AbbVie engage in research and development?
A: Yes, AbbVie is heavily invested in R&D, spending billions annually to develop new therapies and advance scientific research in key therapeutic areas.
